Metagenomi Therapeutics Number of Employees 2022-2025 | MGX
Metagenomi Therapeutics number of employees from 2022 to 2025. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
| Metagenomi Therapeutics Annual Employee Count | |
|---|---|
| 2024 | 202 |
| 2023 | 236 |
| 2022 | 223 |
| 2021 | N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.058B | $0.052B |
| Metagenomi Therapeutics Inc. is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. Metagenomi Therapeutics Inc., formerly known as Metagenomi Inc., is based in EMERYVILLE, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $40.740B | 12.64 |
| BridgeBio Pharma (BBIO) | United States | $15.078B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.364B | 17.67 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.797B | 22.90 |
| Bausch Health Cos (BHC) | Canada | $2.136B | 1.52 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.283B | 9.24 |
| Taysha Gene Therapies (TSHA) | United States | $1.276B | 0.00 |
| Personalis (PSNL) | United States | $0.830B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.417B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.180B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |